|
CH396941A
(de)
|
1959-08-10 |
1965-08-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer sekundärer Amine
|
|
GB884663A
(en)
|
1958-11-06 |
1961-12-13 |
Ciba Ltd |
New amines and processes for their manufacture
|
|
GB1200886A
(en)
|
1966-09-23 |
1970-08-05 |
Allen & Hanburys Ltd |
Phenylaminoethanol derivatives
|
|
US3509153A
(en)
*
|
1967-03-24 |
1970-04-28 |
Miles Lab |
5-phenyl (or 5-phenylalkyl)-2-(omega-(4-phenyl-1-piperazinyl)alkyl)tetrazoles
|
|
DE2710997C3
(de)
|
1977-03-14 |
1980-08-14 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US4569354A
(en)
|
1982-03-22 |
1986-02-11 |
Boston University |
Method and apparatus for measuring natural retinal fluorescence
|
|
ZA848004B
(en)
*
|
1983-10-19 |
1985-06-26 |
Hoffmann La Roche |
Phenoxypropanolamines
|
|
JPH0228112A
(ja)
|
1988-04-21 |
1990-01-30 |
Kaken Pharmaceut Co Ltd |
点眼用眼圧調整剤
|
|
US5135955A
(en)
|
1988-04-25 |
1992-08-04 |
Eli Lilly And Company |
Propanamine derivatives
|
|
IT1240427B
(it)
|
1990-03-02 |
1993-12-15 |
Ministero Dall Uni E Della Ric |
Arilpropilammine ad azione antifungina
|
|
EP0525360B1
(en)
|
1991-07-30 |
1998-03-25 |
Korea Research Institute Of Chemical Technology |
Novel phenylacetamide derivatives and processes for the preparation thereof
|
|
AU3481593A
(en)
|
1992-01-29 |
1993-09-01 |
Smithkline Beecham Corporation |
N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
|
|
US5604229A
(en)
*
|
1992-10-21 |
1997-02-18 |
Yoshitomi Pharmaceutical Industries, Ltd. |
2-amino-1,3-propanediol compound and immunosuppressant
|
|
US5958973A
(en)
*
|
1993-09-03 |
1999-09-28 |
Gilead Sciences, Inc. |
Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
|
|
AU679834B2
(en)
|
1994-01-19 |
1997-07-10 |
Byk Nederland Bv |
Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
|
|
US5541228A
(en)
|
1994-10-14 |
1996-07-30 |
Bristol-Myers Squibb Co. |
Melatonergic agents
|
|
US5693804A
(en)
*
|
1994-11-17 |
1997-12-02 |
Molecular Geriatrics Corporation |
Substituted 1-aryl-3-piperazin-1'-yl propanones
|
|
JPH0940646A
(ja)
*
|
1995-07-27 |
1997-02-10 |
Yamanouchi Pharmaceut Co Ltd |
ベンゼン縮合環誘導体又はその塩
|
|
US5641750A
(en)
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
|
US6878544B2
(en)
|
1996-04-19 |
2005-04-12 |
Neurotech Sa |
Retinal cell lines with extended life-span and their applications
|
|
US6090624A
(en)
|
1996-04-19 |
2000-07-18 |
Brown University Research Foundation |
Immortalized retinal cell lines and their applications
|
|
FR2747690B1
(fr)
|
1996-04-19 |
1998-06-12 |
Neurotech Sa |
Lignees immortalisees de cellules retiniennes et leurs applications au traitement de differents troubles primaires ou secondaires ophtalmologiques ou neurologiques
|
|
AUPO235996A0
(en)
|
1996-09-16 |
1996-10-10 |
Garvan Institute Of Medical Research |
Method of cell culture
|
|
CA2216439A1
(en)
|
1996-09-25 |
1998-03-25 |
Derek Van Der Kooy |
Pharmaceuticals containing retinal stem cells
|
|
DE19643592A1
(de)
|
1996-10-22 |
1998-04-23 |
Bayer Ag |
Verfahren zur Herstellung von alpha-Alkoxy-alpha-trifluormethyl-arylessigsäureestern und -arylessigsäuren
|
|
US6713300B1
(en)
|
1997-02-27 |
2004-03-30 |
University Of Utah Research Foundation |
Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter
|
|
TW593331B
(en)
|
1997-07-25 |
2004-06-21 |
Inspire Pharmaceuticals Inc |
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
|
|
US6051605A
(en)
|
1997-08-08 |
2000-04-18 |
Warner-Lambert Company |
Method of treating psychosis and schizophrenia
|
|
US6171837B1
(en)
|
1997-09-29 |
2001-01-09 |
The Trustees Of Columbia University In The City Of New York |
Mouse and human 9-cis-retinol dehydrogenase
|
|
WO1999029279A2
(en)
|
1997-12-05 |
1999-06-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Long-term survival and regeneration of central nervous system neurons
|
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
|
ATE402253T1
(de)
|
1999-01-05 |
2008-08-15 |
Aventis Pharma Sa |
Humane adulte astrozyten, sowie deren herstellung und verwendung
|
|
AU6391000A
(en)
|
1999-07-28 |
2001-02-19 |
Genentech Inc. |
Method of preventing the injury or death of retinal cells and treating ocular diseases
|
|
EP1107003A1
(en)
|
1999-12-09 |
2001-06-13 |
Trophos |
Methods for screening compounds active on neurons
|
|
US6406840B1
(en)
|
1999-12-17 |
2002-06-18 |
Biomosaic Systems, Inc. |
Cell arrays and the uses thereof
|
|
AU1464101A
(en)
|
1999-12-21 |
2001-07-03 |
Gpi Nil Holdings, Inc. |
Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
|
|
CA2397194C
(en)
|
2000-01-20 |
2011-05-17 |
Mark E. Duggan |
Alpha v integrin receptor antagonists
|
|
WO2001083714A2
(en)
|
2000-05-02 |
2001-11-08 |
Central Institute For The Deaf |
Composition and methods for treating photoreceptor degeneration
|
|
US20020009713A1
(en)
|
2000-05-11 |
2002-01-24 |
Miller Freda D. |
Methods for identifying modulators of neuronal growth
|
|
SK152003A3
(en)
*
|
2000-07-13 |
2004-07-07 |
Sankyo Co |
Amino alcohol derivatives
|
|
JP2002167382A
(ja)
*
|
2000-07-13 |
2002-06-11 |
Sankyo Co Ltd |
アミノアルコ−ル誘導体
|
|
JP2002053575A
(ja)
*
|
2000-08-09 |
2002-02-19 |
Sankyo Co Ltd |
アミノアルコ−ル類
|
|
US20030032078A1
(en)
|
2001-01-23 |
2003-02-13 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the treatment of macular and retinal degenerations
|
|
DE10141018A1
(de)
|
2001-08-22 |
2003-03-13 |
Eth Zuerich Eidgenoessische Te |
Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
|
|
KR100836547B1
(ko)
*
|
2002-01-11 |
2008-06-10 |
상꾜 가부시키가이샤 |
아미노 알코올 유도체 또는 포스폰산 유도체 및 이들을함유하는 의약 조성물
|
|
JP4771511B2
(ja)
*
|
2003-07-08 |
2011-09-14 |
第一三共株式会社 |
アミノアルコ−ル誘導体又はホスホン酸誘導体を含有する医薬組成物
|
|
JP2006506970A
(ja)
|
2002-07-12 |
2006-03-02 |
ユニバーシティ オブ ワシントン |
神経細胞の延長されたインビトロ培養のための方法および系
|
|
DE10235312A1
(de)
|
2002-08-01 |
2004-02-12 |
Basf Ag |
Verfahren zur Herstellung von Aminoalkoxybenzylaminen und Aminoalkoxybenzonitrilen als Zwischenprodukte
|
|
WO2004052227A2
(en)
|
2002-12-06 |
2004-06-24 |
Alcon, Inc. |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases
|
|
AU2004216898A1
(en)
*
|
2003-03-04 |
2004-09-16 |
Pfizer Products Inc. |
Use of EP2 selective receptor agonists in medical treatment
|
|
EP2324823A3
(en)
|
2003-03-14 |
2011-11-16 |
University of Washington |
Retinoid replacements and opsin agonists and methods for the use thereof
|
|
WO2005012506A2
(en)
|
2003-07-30 |
2005-02-10 |
Acucela, Inc. |
Extended primary retinal cell culture and stress models, and methods of use
|
|
AU2004268455B2
(en)
|
2003-08-29 |
2009-12-17 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
|
US7706863B2
(en)
|
2004-01-21 |
2010-04-27 |
University Of Washington |
Methods for assessing a physiological state of a mammalian retina
|
|
US7566808B2
(en)
|
2004-02-17 |
2009-07-28 |
President And Fellows Of Harvard College |
Management of ophthalmologic disorders, including macular degeneration
|
|
BRPI0513915A
(pt)
*
|
2004-08-26 |
2008-05-20 |
Pfizer |
compostos aminoeteroarila enantiomericamente puros como inibidores de proteìna quinase
|
|
TWI359810B
(en)
*
|
2004-11-04 |
2012-03-11 |
Mitsubishi Tanabe Pharma Corp |
Carboxylic acid derivative containing thiazole rin
|
|
US20060252107A1
(en)
|
2005-02-22 |
2006-11-09 |
Acucela, Inc. |
Compositions and methods for diagnosing and treating retinal diseases
|
|
CA2602397A1
(en)
*
|
2005-03-22 |
2006-09-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Therapeutic agent for solid tumor
|
|
US8098907B2
(en)
|
2005-07-01 |
2012-01-17 |
Siemens Corporation |
Method and system for local adaptive detection of microaneurysms in digital fundus images
|
|
TW200744567A
(en)
|
2005-09-23 |
2007-12-16 |
Alcon Inc |
Phenylethylamine analogs and their use for treating glaucoma
|
|
JP5137207B2
(ja)
*
|
2005-11-01 |
2013-02-06 |
アレイ バイオファーマ、インコーポレイテッド |
グルコキナーゼ活性化因子
|
|
PL1966130T3
(pl)
*
|
2005-12-23 |
2014-05-30 |
Zealand Pharma As |
Zmodyfikowane związki mimetyczne lizyny
|
|
JP2009523134A
(ja)
|
2006-01-13 |
2009-06-18 |
マクギル ユニバーシティー |
抗うつ作用ならびに睡眠誘発性を有する新規なメラトニンリガンド
|
|
EP2004166A2
(en)
|
2006-03-31 |
2008-12-24 |
La Jolla Pharmaceutical Company |
Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
|
|
CN101466670B
(zh)
*
|
2006-04-07 |
2013-04-17 |
梅特希尔基因公司 |
组蛋白脱乙酰酶抑制剂
|
|
RU2419625C2
(ru)
*
|
2006-05-23 |
2011-05-27 |
Айрм Ллк |
Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы
|
|
WO2008011484A2
(en)
*
|
2006-07-18 |
2008-01-24 |
Bethesda Pharmacology Associates, Llc |
Nicotinic desensitizers and methods of selecting, testing, and using them
|
|
JP4583500B2
(ja)
*
|
2006-07-28 |
2010-11-17 |
ファイザー・プロダクツ・インク |
Ｅｐ２作動薬
|
|
CA2681850C
(en)
|
2007-04-20 |
2013-07-23 |
Acucela Inc. |
Styrenyl derivative compounds for treating ophthalmic diseases and disorders
|
|
TW200906389A
(en)
*
|
2007-05-25 |
2009-02-16 |
Daiichi Sankyo Co Ltd |
Pharmaceutical composition comprising of therapeutic or prophylactic agents for hepatitis
|
|
KR101196680B1
(ko)
|
2007-06-29 |
2012-11-06 |
어큐셀라 인코포레이티드 |
안과 질환 및 장애 치료용 알키닐 페닐 유도체 화합물
|
|
US7973079B2
(en)
*
|
2007-09-27 |
2011-07-05 |
Revision Therapeutics, Inc. |
Methods and compounds for treating retinol-related diseases
|
|
RU2541430C2
(ru)
|
2007-10-05 |
2015-02-10 |
Акусела Инк. |
Композиции и способы лечения нейродегенеративных заболеваний
|
|
AU2008316688A1
(en)
*
|
2007-10-25 |
2009-04-30 |
Achaogen, Inc. |
Carbacephem beta-lactam antibiotics
|
|
MX2010004718A
(es)
|
2007-11-01 |
2010-07-28 |
Acucela Inc |
Compuestos derivados de amina para tratar enfermedades y trastornos oftalmicos.
|
|
WO2009113637A1
(ja)
*
|
2008-03-12 |
2009-09-17 |
東ソー株式会社 |
新規なチアゾール誘導体、チアゾール誘導体固定化マトリックス、及びそれらの製造方法
|
|
NZ592057A
(en)
|
2008-09-05 |
2013-01-25 |
Acucela Inc |
Sulfur-linked compounds for treating opthalmic diseases and disorders
|
|
BRPI0919920A2
(pt)
|
2008-10-22 |
2016-02-16 |
Acucela Inc |
compostos para tratamento de doenças e desordens oftálmicas
|
|
EP2448569B1
(en)
|
2009-07-02 |
2021-10-27 |
Acucela, Inc. |
Pharmacology of visual cycle modulators
|
|
GB2474120B
(en)
*
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
HK1210969A1
(en)
|
2012-01-20 |
2016-05-13 |
奥克塞拉有限公司 |
Substituted heterocyclic compounds for disease treatment
|
|
TW201406707A
(zh)
|
2012-05-04 |
2014-02-16 |
Acucela Inc |
用以治療糖尿病性視網膜病變及其他眼部疾病之方法
|